|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 193.94 USD | +0.62% |
|
-1.52% | -19.48% |
| 15/06 | Citigroup Adjusts Price Target on ResMed to $270 From $340, Maintains Buy Rating | MT |
| 15/06 | Analyst recommendations: Accenture, Caesars Entertainment, Roku, Adobe, Salesforce… |  |
49ef8e488d79.y_Z7i9Z0E6148-fSF64MHBvidxBg0wE9ypz5YZvitQ4.s9sSvokuavpLtai4LuNkKX2bOV4ViWxLo8qQNa_Ph02pwSO_ph5WmB2B1w~f2028d308dda21288dbb999b6ce18228
- Stock Market
- Stocks
- RMD Stock
- Charts ResMed, Inc.
- News Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition